ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2514

Racial/Ethnic Trends in Incidence and Prevalence of Rheumatoid Arthritis in a Large Multi-Ethnic Managed Care Population

Aniket A. Kawatkar1, Cecilia Portugal1, Li-Hao Chu2 and Rajan Iyer3, 1Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, 2Department of Research and Evaluation,, Kaiser Permanente Southern California, Pasadena, 3Department of Research and Evaluation,, Kaiser Permanente Southern California, Pasadena, CA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Epidemiologic methods, longitudinal studies, race/ethnicity and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: ACR/ARHP Combined Epidemiology Abstract Session

Session Type: Combined Abstract Sessions

Background/Purpose: As epidemiologic studies throughout the world have shown significant variations, we sought to characterize racial differences in longitudinal epidemiologic trends of adult rheumatoid arthritis (RA) in a large, racially diverse, managed care organization. The study objective was to estimate racial/ethnic differences in incidence density (ID) and prevalence rates (PR) of RA over time, while adjusting for age, and gender.

Methods: This was a retrospective population based study using active members from a large managed care health plan, during 01/01/2002 and 12/31/2010. RA patients were identified using a diagnosis code for RA in combination with the use of a disease modifying antirheumatic treatment within a year of the diagnosis code date. Subjects were required to be between the ages of 18 years and 100 years at the time of diagnosis. Non-RA adult health plan members informed the denominator for the ID and PR rates which were calculated on an annual basis. The longitudinal trend of ID and PR across 2002 to 2010, was further stratified by race/ethnic groups (Caucasian; Hispanic; African American; Asian and Other race); age (18-34; 35-44; 45-54; 55-64; and >= 65), and gender. Negative binomial regression models were used to estimate age, gender and race, adjusted rate ratios, for incidence density (aIDr) and prevalence (aPRr). The negative binomial models also included yearly dummy indicators to evaluate the statistical significance (alpha 0.05) in changes of these rates overtime.

Results: During the study period, a total of 8,108 incident cases and 58,644 prevalent cases of RA were identified. The majority of incident (76.9%) and prevalent (77.8%) cases were females. The major race/ethnic group was Caucasians, in the incident (55.8%) as well as the prevalent (64.2%) cases. Due to the predominance of females, the negative binomial models were stratified by gender. For females, the aIDr (mean (95% CI) with Caucasians as reference category) was as follows: Asian 0.7 (0.51-0.89); African Americans 1.0 (0.77-1.35); Hispanics 0.6 (0.45-0.78) and other race 0.9 (0.72-1.25). The aPRr in females (with Caucasians as reference category) was as follows: Asian 0.69 (0.56-0.83); African Americans 1.02 (0.84-1.24); Hispanics 0.45 (0.37-0.55) and other race 0.88 (0.73-1.07). Additionally, as compared to the 18-34 year age group, all other age groups had significantly higher aIDr and aPRr in both genders. Lastly, as compared to reference year 2002, the time trend for aPRr confirmed a statistically significant increase in prevalence rates in both genders.

Conclusion: We find evidence of racial differences in epidemiologic trends in RA with Asians and Hispanics having significantly lower incidence density and prevalence rates as compared to Caucasians. We also find evidence on increase in incidence and prevalence of RA with increasing age and also increase in prevalence rates over time.


Disclosure:

A. A. Kawatkar,
None;

C. Portugal,
None;

L. H. Chu,
None;

R. Iyer,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/racialethnic-trends-in-incidence-and-prevalence-of-rheumatoid-arthritis-in-a-large-multi-ethnic-managed-care-population/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology